Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | HTR1A | P08908 | 1/20 | 0.52 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | OPRM1 | P35372 | 10/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propiram SCHEMBL38655379 | 1.00 | MEN1 (0.52) | MEN1KMT2AHTR1AACHEOPRM1 | |
| Propiram SCHEMBL3093165 | 0.99 | MEN1 (0.52) | MEN1KMT2AHTR1AACHEOPRM1 | |
| Propiram SCHEMBL29725982 | 0.94 | MEN1 (0.48) | MEN1KMT2AHTR1AACHEOPRM1 | |
| Propiram SCHEMBL11079155 | 0.94 | MEN1 (0.48) | MEN1KMT2AHTR1AACHEOPRM1 | |
| Propiram SCHEMBL592478 | 0.94 | MEN1 (0.48) | MEN1KMT2AHTR1AACHEOPRM1 | |
| SCHEMBL26930970 | 0.85 | OPRM1 (0.43) | MEN1KMT2AHTR1AOPRM1SIGMAR1 | |
| Phenampromide SCHEMBL907884 | 0.81 | OPRM1 (0.47) | MEN1KMT2AOPRM1ALDH1A1 | |
| Phenampromide SCHEMBL907886 | 0.81 | OPRM1 (0.47) | MEN1KMT2AOPRM1ALDH1A1 | |
| Phenampromide SCHEMBL11661873 | 0.80 | ALDH1A1 (0.49) | MEN1KMT2AOPRM1ALDH1A1 | |
| Phenampromide SCHEMBL11661877 | 0.80 | ALDH1A1 (0.49) | MEN1KMT2AOPRM1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 7972 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250319074-A1 | TREATMENT AND MANAGEMENT OF AUGMENTATION IN RESTLESS LEGS SYNDROME | UNIV EAST CAROLINA (US) | 2025-10-16 | — | — | US | claimed |
| US-12383743-B2 | Treatment of addiction and dependency | TACA JR ARTURO C (US) | 2025-08-12 | — | — | US | claimed |
| US-20250228771-A1 | ALKALINE INTRAORAL PRODUCTS | EMPLICURE AB (publ) (SE) | 2025-07-17 | — | — | US | claimed |
| EP-4581017-A1 | NEW N-HETEROARYLBENZAMIDES DERIVATIVES AS FLT3 INHIBITORS | Biodol Therapeutics (FR) | 2025-07-09 | — | — | EP | claimed |
| EP-4565202-A1 | ALKALINE INTRAORAL PRODUCTS | EMPLICURE AB (publ) (SE) | 2025-06-11 | — | — | EP | claimed |
| EP-4561699-A1 | SELECTIVE OPIOID RECEPTOR AGONISTS AND ANTAGONISTS | The United States of America, as represented by the Secretary, Department of Health and Human Services (US) | 2025-06-04 | — | — | EP | claimed |
| US-12133922-B2 | Abuse resistant capsule | R.P. SCHERER TECHNOLOGIES, LLC (US) | 2024-11-05 | — | — | US | claimed |
| US-20240288374-A1 | PLASMONIC NANOPARTICLE PLATFORM FOR ANALYTE DETECTION | Zymeron Corporation | 2024-08-29 | — | — | US | claimed |
| WO-2024172892-A1 | PLASMONIC NANOPARTICLE PLATFORM FOR ANALYTE DETECTION | Zymeron Corporation (US) | 2024-08-22 | — | — | WO | claimed |
| EP-3768679-B1 | BIASED POTENT OPIOID-LIKE AGONISTS AS IMPROVED MEDICATIONS TO TREAT CHRONIC AND ACUTE PAIN AND METHODS OF USING THE SAME | US HEALTH (US) | 2024-06-26 | — | — | EP | claimed |
| WO-1995014460-A1 | OPIOID FORMULATIONS FOR TREATING PAIN | EURO-CELTIQUE S.A. (LU) | 1995-06-01 | — | — | WO | claimed |
| EP-0647448-A1 | Orally administrable opioid formulations having extended duration of effect | Euroceltique S.A. (LU) | 1995-04-12 | — | — | EP | claimed |
| CN-1017211-B | BAKING PROCESS FOR PEANUTS | KOYO FOODS LTD (JP) | 1992-07-01 | — | — | CN | claimed |
| CN-85101678-A | Processing method and device thereof are fried in shallow oil in the roasting of peanut | — | 1987-01-31 | — | — | CN | claimed |
| EP-0152379-A2 | Process for preparing pharmaceutical compositions containing unilamellar liposomes | CIBA-GEIGY AG (CH) | 1985-08-21 | — | — | EP | claimed |
| US-4486436-A | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same | ANALGESIC ASSOCIATES (US) | 1984-12-04 | — | — | US | claimed |
| US-4479956-A | Analgesic compositions comprising propiram and methods of using same | ANALGEIC ASSOCIATES (US) | 1984-10-30 | — | — | US | claimed |
| US-4464376-A | Analgesic and anti-inflammatory compositions comprising caffeine and methods of using same | RICHARDSON-VICKS, INC. (US) | 1984-08-07 | — | — | US | claimed |
| US-4126684-A | 4-AMINO-3-P-HALOPHENYLBUTYRIC ACIDS AND THEIR DERIVATIVES USED IN THE CONTROL OF NARCOTIC ABUSE | CIBA-GEIGY CORPORATION (US) | 1978-11-21 | — | — | US | claimed |
| US-4070494-A | Enteral pharmaceutical compositions | BAYER AKTIENGESELLSCHAFT (DT) | 1978-01-24 | — | — | US | claimed |